Innoplexus

Josua Jordi is a biochemist ETH by training and completed a Ph.D. Jean-Michel Cosséry is a senior healthcare executive with global leadership experience in research, biotech, and commercial roles within Eli Lilly, GE Healthcare, Kymab Ltd, Immunocore Ltd. Bettina Ernst is a biotech entrepreneur and investor. Henning Böttcher is the former head of medicinal chemistry at Merck KGaA. Florian Engert is a neuroscience expert and tenured professor at Harvard University. Gerd Meyer is Head of Plexus Ventures CH, a leading global development & licensing firm. Thomas Weller is the former head of medicinal chemistry at Idorsia/Actelion.

Before acting as GliaPharm’s co-CEO, Dr.Lengacher has been a research director at Ecole Polytechnique Fédérale de Lausanne (EPFL, Switzerland) for over 10 years. GliaPharm was created in 2016 as a company built on three decades of research, performed in the laboratory of Prof. We are taking the work of decades on the role of glial cells in brain function and health for the benefit of patients suffering challenging disorders. GliaPharm is located at Campus Biotech in Geneva, Switzerland. Sylvain Lengacher is a molecular biologist and has over 20 years of experience in the field of neuroscience research, biotechnology management, and technology transfer. Charles Finsterwald is a neuroscientist with expertise in molecular, cellular and cognitive neuroscience. François Jenck is a Neuropharmacologist with 25+y R&D leadership experience in Translational Neuropharmacology at Idorsia (startup), Actelion (biotech), Organon-AKZOnobel (mid pharma) and Roche (big pharma); since 2018 at Axl.neuro as independent R&D advisor for accelerating Neuroscience applications in 2020-Healthcare Biotechs. Dr Lowe has broad experience in CNS drug discovery, translational medicine and product development, generating diverse clinical candidates in psychiatry, neurology and pain that moved into clinical trials and the market.

The management of Inthera Bioscience AG has more that 100 years of combined experience within biotech/pharma industry. Their expertise covers the entire value chain from target discovery and validation to early drug discovery, medicinal chemistry, pre-clinical and toxicology works as well as early clinical development. Furthermore the team has substantial experience in business development, deal transactions in general and in people management.

Curtis has created Technical Files to support the CE Mark, prepared successful submissions to Health Canada, and several Pacific Rim countries. Mootoo helped unlock additional revenue by addressing productivity gaps and driving operational consistency. Steiner founded Pharmaceutical Discovery Corporation ("PDC"), a biopharmaceutical corporation and is an inventor of its Technosphere™ Technology and MedTone™ Inhaler. Steiner founded and was Chairman of the board and President of Clinical Technologies Associates, Inc. Langer’s research laboratory at MIT is the largest academic biomedical engineering lab in the world, maintaining over $15 million in annual grants and over 100 researchers. Mercuri served as the Global Head for cardio, vascular, metabolic and renal disease Therapeutic Area for translational sciences and clinical development, Chief Medical Advisor to the Head of Development, and Head of Clinical Development for the Americas. Mercuri served on the Medical School Faculty and as the Co-Director of the Division of Vascular Ultrasound. Mercuri published over 100 articles in peer-reviewed medical and scientific journals in collaboration with leading scientists from around the world.

Manoj Gopalkrishnan is the founder and CEO of . Nidhi Mathur is the Chief Business Officer of . Krishna Vishal Vemula is a Solutions Architect at . Bhavna Kandra is a Data Scientist at . Prantik Chakraborty is a Data Engineer at . Rita Bhui is a Data Scientist at . We believe molecular testing based diagnostics is the next frontier of innovation in Healthcare. Done in partnership with a leading Genomics research Lab.

Stephen Remondi is the Founder and CEO of Xsphera Biosciences. Michael Perricone is the Chief Scientific Officer and a Co-Founder of Xsphera Biosciences. Amir Aref is the Vice President of Xsphera Biosciences. Kazuhito Ishikawa is the Vice President of Sales and Business Development at Xsphera with over 30 years of experience in the software and IT industry. Aaron Goldman is a deeply engaged advisor to Xsphera’s leadership team and leads the effort tumor histology, biomarker development, and optimization of next-generation therapies within the platform. Aaron is a board member of Mass General Brigham Gene and Cell Therapy Center. Paweletz successfully built platforms to look at disease biomarkers in body fluids and oversaw research activities spanning the spectrum from early-stage discovery to the clinic. Jenkins is the inaugural Termeer Early Career Investigator in Systems Pharmacology and a member of the Laboratory for Systems Pharmacology at Harvard Medical School.